Knowledge

Dexamethasone suppression test

Source 📝

29: 280:
A normal result is a decrease in cortisol levels upon administration of low-dose dexamethasone. Results indicative of Cushing's disease involve no change in cortisol on low-dose dexamethasone, but inhibition of cortisol on high-dose dexamethasone. If the cortisol levels are unchanged by low- and
271:
A low dose of dexamethasone suppresses cortisol in individuals with no pathology in endogenous cortisol production. A high dose of dexamethasone exerts negative feedback on pituitary neoplastic ACTH-producing cells (Cushing's disease), but not on ectopic ACTH-producing cells or adrenal adenoma
267:
Low-dose and high-dose variations of the test exist. The test is given at low (usually 1–2 mg) and high (8 mg) doses of dexamethasone, and the levels of cortisol are measured to obtain the results.
281:
high-dose dexamethasone, then other causes of Cushing's syndrome must be considered with further work-up necessary. After the high-dose dexamethasone, it may be possible to make further interpretations.
448:
Cole MA, Kim PJ, Kalman BA, Spencer RL (February 2000). "Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies".
197:
The DST was historically used for diagnosing depression, but by 1988 it was considered to be "at best, severely limited in its clinical ability" for this purpose.
248:- This involves giving an oral dose of dexamethasone at six-hourly intervals for 2 days, with the cortisol level measured 6 hours after the final dose was given 616: 682: 493:"Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome" 589:
Theodore C. Friedman, M.D., Ph.D. Professor of Medicine-UCLA Chairman, Department of Internal Medicine Charles R. Drew University (2013).
336:
is likely. If an adrenal tumor is not apparent, a chest CT and abdominal CT is indicated to rule out a different tumor secreting ACTH.
814: 609: 242:- An oral dose of dexamethasone is given between 11pm and midnight, and the cortisol level is measured at 8 - 9am the next morning 119: 322:
should be considered because the pituitary still retains some feedback control. A pituitary MRI would be needed to confirm.
652: 602: 577: 568:
Longo, Dan L.; Fauci, Anthony S.; Kasper, Dennis L.; Hauser, Stephen L.; Jameson, J. Larry; Loscalzo, Joseph (2012),
353: 346: 715: 558:
Kumar, Abbas, Fausto. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier-Saunders; New York, 2005
156: 114: 77: 809: 411:"How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test" 492: 210: 82: 763: 720: 646: 594: 677: 218: 770: 590: 758: 349: 333: 305: 191: 725: 319: 8: 59: 473: 461: 707: 626: 573: 541: 514: 465: 430: 426: 384: 477: 630: 504: 457: 422: 664: 206: 533: 376: 308:, not disease (i.e., the hypercortisolism is not driven by ACTH hypersecretion) 672: 214: 129: 803: 745: 737: 702: 205:
Dexamethasone is an exogenous steroid that provides negative feedback to the
187: 179: 33: 788: 780: 545: 518: 509: 469: 388: 434: 410: 28: 124: 87: 624: 638: 183: 694: 491:
Isidori AM, Kaltsas GA, Mohammed S, et al. (November 2003).
217:
receptors in the anterior pituitary gland, which lie outside the
532:
Johnson, Donavon B.; Lopez, Michael J.; Kelley, Brendan (2020).
313:
is not suppressed by low doses, but is suppressed by high doses
186:
levels change in response to oral doses or an injection of
572:(18th ed.), McGraw Hill Medical, pp. 2897–2898, 567: 490: 447: 408: 375:Dogra, Prerna; Vijayashankar, Narasimha P. (2020). 342:†ACTH as measured prior to dosing of dexamethasone 683:Combined rapid anterior pituitary evaluation panel 531: 374: 801: 610: 213:(ACTH). Specifically, dexamethasone binds to 484: 441: 229:There are several types of DST procedures: 617: 603: 570:Harrison's Principles of Internal Medicine 402: 345:Equivocal results should be followed by a 27: 508: 327:is not suppressed by high or low doses 316:Normal to elevated but not in hundreds 298:is not suppressed by low or high doses 802: 370: 368: 221:, resulting in regulatory modulation. 598: 409:Nierenberg AA, Feinstein AR (1988). 304:Primary hypercortisolism is likely; 55: 365: 190:. It is typically used to diagnose 13: 224: 14: 826: 262: 815:Dynamic endocrine function tests 427:10.1001/jama.1988.03720110061036 377:"Dexamethasone Suppression Test" 354:inferior petrosal sinus sampling 347:corticotropin-releasing hormone 52:proopiomelanocortin derivatives 754:Dexamethasone suppression test 716:Radioactive iodine uptake test 561: 552: 525: 172:dexamethasone suppression test 22:Dexamethasone suppression test 1: 462:10.1016/S0306-4530(99)00045-1 359: 209:to suppress the secretion of 200: 44:assess adrenal gland function 7: 653:digestive system procedures 211:adrenocorticotropic hormone 10: 831: 764:Captopril suppression test 721:Sestamibi parathyroid scan 647:Islet cell transplantation 497:J. Clin. Endocrinol. Metab 182:function by measuring how 58: 779: 736: 693: 663: 637: 540:. StatPearls Publishing. 383:. StatPearls Publishing. 149: 135: 123: 102: 86: 81: 71: 68: 40: 26: 21: 450:Psychoneuroendocrinology 678:Transsphenoidal surgery 275: 771:Fluid deprivation test 510:10.1210/jc.2003-030510 272:(Cushing's syndrome). 257:Dexamethasone-CRT test 759:ACTH stimulation test 334:Ectopic ACTH syndrome 330:Elevated in hundreds 810:Endocrine procedures 726:TRH stimulation test 301:Undetectable or low 178:) is used to assess 219:blood–brain barrier 306:Cushing's syndrome 192:Cushing's syndrome 797: 796: 708:Parathyroidectomy 340: 339: 320:Cushing's disease 165: 164: 48: 47: 822: 631:endocrine system 619: 612: 605: 596: 595: 583: 582: 579:978-0-07174889-6 565: 559: 556: 550: 549: 529: 523: 522: 512: 503:(11): 5299–306. 488: 482: 481: 445: 439: 438: 421:(11): 1699–702. 406: 400: 399: 397: 395: 372: 350:stimulation test 284: 283: 56: 31: 19: 18: 830: 829: 825: 824: 823: 821: 820: 819: 800: 799: 798: 793: 775: 732: 689: 659: 633: 623: 586: 580: 566: 562: 557: 553: 534:"Dexamethasone" 530: 526: 489: 485: 446: 442: 407: 403: 393: 391: 373: 366: 362: 293:Interpretation 278: 265: 252:Intravenous DST 227: 225:Test procedures 207:pituitary gland 203: 168: 167: 166: 53: 36: 17: 12: 11: 5: 828: 818: 817: 812: 795: 794: 792: 791: 785: 783: 777: 776: 774: 773: 768: 767: 766: 761: 756: 748: 742: 740: 734: 733: 731: 730: 729: 728: 723: 718: 710: 705: 699: 697: 691: 690: 688: 687: 686: 685: 675: 673:Hypophysectomy 669: 667: 661: 660: 658: 657: 656: 655: 643: 641: 635: 634: 629:involving the 622: 621: 614: 607: 599: 593: 592: 585: 584: 578: 560: 551: 524: 483: 440: 401: 363: 361: 358: 338: 337: 331: 328: 324: 323: 317: 314: 310: 309: 302: 299: 295: 294: 291: 288: 277: 274: 264: 263:Interpretation 261: 260: 259: 254: 249: 243: 226: 223: 215:glucocorticoid 202: 199: 163: 162: 159: 154: 151: 147: 146: 143: 140: 137: 133: 132: 127: 122: 117: 112: 108: 107: 104: 101: 98: 95: 91: 90: 85: 80: 74: 73: 70: 67: 63: 62: 54: 51: 50: 49: 46: 45: 42: 38: 37: 32: 24: 23: 15: 9: 6: 4: 3: 2: 827: 816: 813: 811: 808: 807: 805: 790: 787: 786: 784: 782: 778: 772: 769: 765: 762: 760: 757: 755: 752: 751: 749: 747: 746:Adrenalectomy 744: 743: 741: 739: 738:Adrenal gland 735: 727: 724: 722: 719: 717: 714: 713: 711: 709: 706: 704: 703:Thyroidectomy 701: 700: 698: 696: 692: 684: 681: 680: 679: 676: 674: 671: 670: 668: 666: 662: 654: 650: 649: 648: 645: 644: 642: 640: 636: 632: 628: 620: 615: 613: 608: 606: 601: 600: 597: 591: 588: 587: 581: 575: 571: 564: 555: 547: 543: 539: 535: 528: 520: 516: 511: 506: 502: 498: 494: 487: 479: 475: 471: 467: 463: 459: 456:(2): 151–67. 455: 451: 444: 436: 432: 428: 424: 420: 416: 412: 405: 390: 386: 382: 378: 371: 369: 364: 357: 355: 351: 348: 343: 335: 332: 329: 326: 325: 321: 318: 315: 312: 311: 307: 303: 300: 297: 296: 292: 289: 286: 285: 282: 273: 269: 258: 255: 253: 250: 247: 244: 241: 237: 236:Overnight DST 234: 233: 232: 230: 222: 220: 216: 212: 208: 198: 195: 193: 189: 188:dexamethasone 185: 181: 180:adrenal gland 177: 173: 160: 158: 155: 152: 148: 144: 141: 138: 134: 131: 128: 126: 121: 118: 116: 113: 110: 109: 105: 99: 96: 93: 92: 89: 84: 79: 76: 75: 65: 64: 61: 57: 43: 39: 35: 34:Dexamethasone 30: 25: 20: 789:Pinealectomy 781:Pineal gland 753: 569: 563: 554: 537: 527: 500: 496: 486: 453: 449: 443: 418: 414: 404: 392:. Retrieved 380: 344: 341: 279: 270: 266: 256: 251: 245: 239: 235: 231: 228: 204: 196: 175: 171: 169: 125:γ-lipotropin 88:β-lipotropin 16:Medical test 394:26 December 246:Two-day DST 130:β-endorphin 804:Categories 627:procedures 538:StatPearls 381:StatPearls 360:References 201:Physiology 665:Pituitary 651:see also 625:Test and 287:Cortisol 639:Pancreas 546:29489240 519:14602765 478:17445446 470:10674279 389:31194457 184:cortisol 695:Thyroid 435:3278149 352:, with 41:Purpose 750:Tests 712:Tests 576:  544:  517:  476:  468:  433:  387:  290:ACTH† 161:  153:  150:  145:  142:  139:  136:  111:  106:  103:  100:  97:  94:  72:  69:  66:  474:S2CID 240:ONDST 157:β-MSH 115:α-MSH 78:γ-MSH 574:ISBN 542:PMID 515:PMID 466:PMID 431:PMID 415:JAMA 396:2020 385:PMID 276:Dose 170:The 120:CLIP 83:ACTH 60:POMC 505:doi 458:doi 423:doi 419:259 238:or 176:DST 806:: 536:. 513:. 501:88 499:. 495:. 472:. 464:. 454:25 452:. 429:. 417:. 413:. 379:. 367:^ 356:. 194:. 618:e 611:t 604:v 548:. 521:. 507:: 480:. 460:: 437:. 425:: 398:. 174:(

Index


Dexamethasone
POMC
γ-MSH
ACTH
β-lipotropin
α-MSH
CLIP
γ-lipotropin
β-endorphin
β-MSH
adrenal gland
cortisol
dexamethasone
Cushing's syndrome
pituitary gland
adrenocorticotropic hormone
glucocorticoid
blood–brain barrier
Cushing's syndrome
Cushing's disease
Ectopic ACTH syndrome
corticotropin-releasing hormone
stimulation test
inferior petrosal sinus sampling


"Dexamethasone Suppression Test"
PMID
31194457

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.